Wegovy vs Mounjaro: Key Differences for UK Patients
Understanding the Switch: Wegovy vs Mounjaro Mechanisms
When switching from Wegovy to Mounjaro in the UK, understanding their different mechanisms is crucial. Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics your body's natural fullness hormone. Mounjaro contains tirzepatide, a dual agonist targeting both GIP and GLP-1 receptors. This dual action may provide different appetite control patterns, though both require clinical assessment to determine suitability. If considering a fresh start with Wegovy, the 0.25mg starter dose provides a gentle introduction to GLP-1 therapy with established clinical evidence from the STEP trials.
Both treatments are prescription-only medicines requiring proper medical supervision. The choice between switching from Wegovy to Mounjaro or continuing with Wegovy depends on individual response, tolerability, and clinical factors. EverydayMeds provides access to both options through our GPhC-registered pharmacy (#9012878), ensuring you receive authentic treatments with proper storage and delivery. Your prescriber can evaluate which treatment aligns best with your weight management goals and medical history.
Pricing Comparison: Wegovy vs Mounjaro Starter Costs
For those switching from Wegovy to Mounjaro in the UK, cost considerations matter significantly. Wegovy's starter dose of 0.25mg costs £79.99 with discount code FIRST40 applied at checkout for new customers. The complete escalation journey spans 16 weeks: 0.5mg (£94.99), 1mg (£99.99), 1.7mg (£139.99), and maintenance 2.4mg (£209.99). Bundle options like the Intro Duo (0.25mg & 0.5mg) provide convenient two-month supply for £169.99. Mounjaro pricing differs, and direct cost comparisons should consider the full treatment duration and individual response rates.
EverydayMeds offers structured bundle options to support consistent treatment without supply gaps. The Gentle Start Trio (0.25mg, 0.25mg, 0.5mg) costs £269.99, perfect for those wanting extended time at lower doses. Returning customers benefit from discount code DOSE25 at checkout. Whether switching from Wegovy to Mounjaro or starting Wegovy fresh, our transparent pricing includes all clinical assessment, prescriber review, and next-day cold-chain delivery costs.
Clinical Evidence: STEP Trials vs Mounjaro Studies
The decision between switching from Wegovy to Mounjaro involves reviewing clinical evidence from different trial programmes. In the STEP 1 trial, patients taking Wegovy alongside diet and exercise achieved approximately 15% average weight loss at 68 weeks versus 2.4% with placebo (Wilding et al., NEJM, 2021). STEP 5 demonstrated sustained weight loss of approximately 15.2% at two years with continued treatment.
Mounjaro's clinical programme shows different results, though direct head-to-head comparisons aren't available due to different trial designs, populations, and endpoints. Both treatments require alongside a reduced-calorie diet and increased physical activity for optimal results. When switching from Wegovy to Mounjaro in the UK, individual clinical response rather than population averages should guide decisions with prescriber support.
How Wegovy Works: GLP-1 Mechanism Explained
Wegovy functions as a GLP-1 receptor agonist, mimicking glucagon-like peptide-1, a natural hormone that regulates appetite and blood sugar. Once injected weekly, semaglutide binds to GLP-1 receptors in the brain's appetite centres, potentially reducing food cravings and promoting earlier satiety during meals. The medication may slow gastric emptying, helping you feel fuller for longer periods after eating. This mechanism explains why dose escalation over 16 weeks is mandatory - your body needs gradual adaptation to avoid gastrointestinal side effects. The proven pathway from 0.25mg starter dose to 2.4mg maintenance allows sustainable appetite regulation while minimising tolerability issues that might otherwise lead to treatment discontinuation.
EverydayMeds Ordering Process: Assessment to Delivery
Starting Wegovy or switching from Wegovy to Mounjaro through EverydayMeds begins with our 3-minute online clinical assessment covering medical history, current medications, and weight management goals. Our qualified prescribers review applications within 3 working days (express 24-hour service available), ensuring clinical appropriateness before dispensing any prescription-only medicine. Once approved, your Wegovy 0.25mg starter dose ships via next-day delivery in temperature-controlled packaging to maintain cold-chain integrity. Each FlexTouch pen arrives with comprehensive patient information, injection guidance, and dose escalation schedule. Our GPhC-registered pharmacy (#9012878) ensures all treatments meet MHRA standards with full traceability and patient support throughout your treatment journey.
Storage Advantages: Wegovy vs Mounjaro Practicality
A key consideration when switching from Wegovy to Mounjaro in the UK involves storage requirements affecting daily convenience. Wegovy pens maintain stability for up to 6 weeks at room temperature below 30°C once removed from refrigeration, compared to Mounjaro's 21-day room temperature limit. This storage advantage benefits frequent travellers, busy professionals, or anyone preferring flexible medication management. Both treatments require initial refrigeration at 2-8°C, but Wegovy's extended room temperature stability reduces anxiety about cold-chain maintenance. The FlexTouch pen design provides consistent dosing with clear visual confirmation of injection completion, supporting treatment adherence whether you're continuing Wegovy or considering alternatives.
Dose Escalation: Why Starting Slow Matters
Whether switching from Wegovy to Mounjaro or beginning Wegovy treatment, understanding dose escalation importance prevents common mistakes. Wegovy's mandatory 4-week intervals at each dose level allow gradual GLP-1 receptor adaptation, minimising nausea, vomiting, and other gastrointestinal effects that cause treatment discontinuation. Skipping doses or escalating too quickly increases side effect risks without improving efficacy. The 0.25mg starter dose may seem minimal, but clinical trials demonstrate this foundation enables successful progression to therapeutic 2.4mg maintenance dose.
Some patients considering switching from Wegovy to Mounjaro assume they can start Mounjaro at higher doses due to prior GLP-1 exposure, but each medication requires individual dose escalation protocols. EverydayMeds' Gentle Start Trio bundle supports patients needing extended time at lower doses, recognising that sustainable weight management prioritises tolerability alongside effectiveness. Your prescriber determines appropriate escalation timing based on individual response and tolerability patterns.
Making Your Choice: Wegovy or Mounjaro Decision Factors
The decision between switching from Wegovy to Mounjaro in the UK should consider multiple factors beyond weight loss percentages. Injection frequency, storage requirements, side effect profiles, and individual response patterns all influence treatment success. Both Wegovy and Mounjaro are available from EverydayMeds - your prescriber can help determine which is right for you based on clinical assessment and treatment goals. Consider practical factors like travel schedules, refrigeration access, and injection day preferences alongside clinical considerations. Cost differences across the full treatment duration, not just starter doses, impact long-term sustainability and adherence to either treatment option.
Start your Wegovy journey with the 0.25mg starter dose using discount code FIRST40, or discuss Mounjaro alternatives through our clinical assessment process. Both treatments require ongoing commitment to diet, exercise, and regular monitoring for optimal results. Our experienced clinical team supports informed decision-making throughout your weight management journey with transparent pricing, reliable supply, and comprehensive patient care.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
